ENDRA Life Sciences Inc (NAS:NDRA)

$ 5.16 -0.305 (-5.58%) Market Cap: 2.77 Mil Enterprise Value: -1.57 Mil PE Ratio: 0 PB Ratio: 0.42 GF Score: 30/100

Q2 2024 ENDRA Life Sciences Inc Earnings Call Transcript
Aug 22, 2024

$15.58 (-0.43%)

Earnings
Q1 2024 ENDRA Life Sciences Inc Earnings Call Transcript
May 14, 2024

$506.97 (-0.48%)

Earnings
Q4 2023 ENDRA Life Sciences Inc Earnings Call Transcript
Mar 28, 2024

$1015 (-29.29%)

Earnings
Q3 2023 ENDRA Life Sciences Inc Earnings Call Transcript
Nov 14, 2023

$1645 (+0.32%)

Earnings
Q2 2023 ENDRA Life Sciences Inc Earnings Call Transcript
Aug 14, 2023

$2196.25 (-3.46%)

Earnings
Q1 2023 ENDRA Life Sciences Inc Earnings Call Transcript
May 15, 2023

$2240 (-8.57%)

Earnings
Q4 2022 ENDRA Life Sciences Inc Earnings Call Transcript
Mar 14, 2023

$6510 (-0.80%)

Earnings
ENDRA Life Sciences Inc Annual Shareholders Meeting Transcript
Nov 29, 2022
Q3 2022 ENDRA Life Sciences Inc Earnings Call Transcript
Nov 14, 2022

$7805.01 (+1.83%)

Earnings
ENDRA Life Sciences Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Sep 12, 2022
Q2 2022 ENDRA Life Sciences Inc Earnings Call Transcript
Aug 15, 2022

$12635.01 (+2.53%)

Earnings
Q4 2020 ENDRA Life Sciences Inc Earnings Call Transcript
Mar 25, 2021

$80850.08

Earnings
Q3 2020 ENDRA Life Sciences Inc Earnings Call Transcript
Nov 16, 2020

$28378.03 (-3.93%)

Earnings
Q2 2020 ENDRA Life Sciences Inc Earnings Call Transcript
Aug 17, 2020

$31500.03 (-2.17%)

Earnings
Q1 2020 ENDRA Life Sciences Inc Earnings Call Transcript
May 14, 2020

$25035.53 (+13.54%)

Earnings
Q4 2019 ENDRA Life Sciences Inc Earnings Call Transcript
Mar 26, 2020

$30975.03 (+1.41%)

Earnings

Q2 2020 ENDRA Life Sciences Inc Earnings Call Transcript

Aug 17, 2020 / 08:30PM GMT

Release Date Price: $31500.03 (-2.17%)

Transcript 8-K10-Q

Operator

Good day, ladies and gentlemen, and welcome to your ENDRA Life Sciences second quarter 2020 earnings call. (Operator Instructions) At this time, it is my pleasure to turn the floor over to your host, David Wells, CFO. Sir, floor is yours.

David Wells

ENDRA Life Sciences Inc - CFO

Thank you, [Karen]. Appreciate it. Good afternoon, and welcome to ENDRA's second quarter 2020 business update and financial conference call. We issued a press release this morning. For those of you who don't have a copy of the release, you can access it in the Investors section of our website at www.endrainc.com.

Before we begin, please note that today's presentation includes forward-looking statements. All statements other than statements of historical facts including statements regarding our strategies, financial condition, operations, costs, plans and objectives, as well as anticipated results of our development and commercialization efforts, and the timing for receipt of required regulatory clearances and

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.